This is a multi-center prospective, observational study of the Quantra System with the QStat Cartridge in trauma patients and patients undergoing liver transplant.
The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic properties of a whole blood sample during coagulation. The QStat Cartridge was developed to monitor hemostasis in patients that may experience a range of coagulopathies of various etiologies, including fibrinolytic defects. These patients include the trauma and liver transplant populations. The cartridge consists of four independent channels each containing different sets of reagents, which provide four measurements performed in parallel yielding five parameters that depict the functional status of a patient's coagulation system. This multi-center, prospective, observational pilot study will evaluate the performance of the Quantra System with the QStat Cartridge as compared to conventional viscoelastic testing methods in blood samples obtained from trauma patients and patients undergoing liver transplant.
Study Type
OBSERVATIONAL
Enrollment
397
Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, United States
University of Colorado
Denver, Colorado, United States
University of Florida Health Shands Hospital
Gainesville, Florida, United States
Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Upon arrival of trauma subject to the emergency department
Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Baseline, immediately before the start of liver transplant surgery
Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During anhepatic phase of liver transplant surgery
Comparison of Quantra Clot Time (CT) to ROTEM Delta INTEM CT results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During post-reperfusion phase of liver transplant surgery
Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Upon arrival of trauma subject to the emergency department
Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Baseline, immediately before the start of liver transplant surgery
Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During anhepatic phase of liver transplant surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Michigan Medical Center
Ann Arbor, Michigan, United States
Ohio State University
Columbus, Ohio, United States
University of Oklahoma Medical Center
Oklahoma City, Oklahoma, United States
Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Texas Tech University Health Sciences Center
El Paso, Texas, United States
University of Virginia Medical Center
Charlottesville, Virginia, United States
Comparison of Quantra Clot Stiffness (CS) to ROTEM Delta EXTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During post-reperfusion phase of liver transplant surgery
Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Upon arrival of trauma subject to the emergency department
Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Baseline, immediately before the start of liver transplant surgery
Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During anhepatic phase of liver transplant surgery
Comparison of Quantra Fibrinogen Contribution (FCS) to ROTEM Delta FIBTEM A20 results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During post-reperfusion phase of liver transplant surgery
Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Upon arrival of trauma subject to the emergency department
Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: Baseline, immediately before the start of liver transplant surgery
Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During anhepatic phase of liver transplant surgery
Comparison of Quantra Clot Stability to Lysis (CSL) to ROTEM Delta EXTEM ML results
Coagulation function assessed by Quantra and ROTEM Delta
Time frame: During post-reperfusion phase of liver transplant surgery